-+ 0.00%
-+ 0.00%
-+ 0.00%

Kalvista Pharmaceuticals Showcases EKTERLY as First Oral On-Demand Therapy for Hereditary Angioedema

路透·01/08/2026 21:30:58

登錄查看新聞詳情